Aurobindo Pharma Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1986. The current market capitalisation stands Rs 39271 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 524804. and also listed on National Stock Exchange (NSE) with NSE code as AUROPHARMA.
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of various pharmaceutical products in India. It produces oral and injectable generic formulations, and active pharmaceutical ingredients in the areas of antibiotic, anti-retroviral, cardiovascular, central nervous system, gastroenterological, anti-diabetic, and anti-allergy areas. The also provides custom research and manufacturing services to bio-tech and pharmaceutical community; develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. In addition, it manufactures and sells proteins, vitamins, minerals, and supplements; and sports drinks, dairy products, snacks, and pre-prepared diet meals. The also exports its products to approximately 150 countries, including the United States and Europe. It serves multinational companies. Aurobindo Pharma Limited was founded in 1986 and is based in Hyderabad, India.
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.
Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, investment goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs.